Chemotherapy-induced peripheral neuropathy (CIPN) is a common and clinically relevant side effect of chemotherapy. Approximately 50% of all leukemia, lymphoma, colorectal- and breast cancer patients are affected.
CIPN is induced by neurotoxic chemotherapeutic agents and can manifest with sensory and/or motor deficits. It is associated with significant disability and poor recovery. Common symptoms include pain, altered sensation, reduced or absent reflexes, muscle weakness, reduced balance control and insecure gait.
These symptoms not only affect activities of daily living, subsequently reducing patients’ quality of life, they have far more become a decisive limiting factor for medical therapy, causing treatment delays, dose reductions, or even discontinuation of therapy, which can affect the outcome and compromise survival. To date, CIPN cannot be prevented and its occurrence presents a diagnostic dilemma since approved and effective treatment options are lacking.
Promising results have recently been achieved with exercise. We have revealed that sensorimotor training (SMT) or whole body vibration (WBV) can reduce the symptoms of CIPN and attenuate motor and sensory deficits. We furthermore detected a tendency that it may also have a preventive effect on the onset of CIPN.
We are therefore conducting a prospective, multicentre, controlled clinical trial involving 236 oncological patients receiving either oxaliplatin (N = 118) or vinca-alkaloid (N = 118) who are randomized to one of two interventions (SMT or WBV) or a treatment as usual (TAU) group. Primary endpoint is the time to incidence of neurologically confirmed CIPN. Secondary endpoints are pain, maintenance of the functionality of sensory as well as motor nerve fibres as well as the level of physical activity. The baseline assessment is performed prior to the first cycle of chemotherapy. Subsequent follow-up assessments are conducted at 12 weeks, after completion of chemotherapy, and at a 3-month follow-up. Patients who develop CIPN receive an additional assessment at this time point, as it represents the primary endpoint.
We hypothesize that SMT and WBV prevent the onset or delay the progression of CIPN, decrease the likelihood of dose reductions or discontinuation of cancer treatment and improve patients’ quality of life.
Deutsche Register Klinischer Studien (DRKS00006088, registered 07.05.2014).
Richardson JK, Ashton-Miller JA. Peripheral neuropathy: an often-overlooked cause of falls in the elderly. Postgrad Med. 1996;99(6):161–72. CrossRef
Vogt TKJ, Barth J, Ingel K. Klinische Relevanz und Therapie von therapieassotiierten Polyneuropathien bei Patienten mit Tumorerkrankung. In: Arbeitsgemeinschaft für Krebserkrankungen; 2010.
Smith EM, Cohen JA, Pett MA, Beck SL. The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums. Cancer Nurs. 2010;33(3):173–83. CrossRefPubMed
Wonders KY, Reigle BS, Drury DG. Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise. Oncol Rev. 2010;4:117–25. CrossRef
Taube W, Gruber M, Beck S, Faist M, Gollhofer A, Schubert M. Cortical and spinal adaptations induced by balance training: correlation between stance stability and corticospinal activation. Acta Physiol (Oxf). 2007;189(4):347–58. CrossRef
Freeman MA, Dean MR, Hanham IW. The etiology and prevention of functional instability of the foot. J Bone Joint Surg Br. 1965;47(4):678–85. PubMed
Steimann M, Kerschgens C, Barth J. Rehabilitation bei Chemotherapieinduzierter Polyneuropathie. Onkologe. 2011;17:940–7. CrossRef
Bogaerts A, Delecluse C, Boonen S, Claessens AL, Milisen K, Verschueren SM. Changes in balance, functional performance and fall risk following whole body vibration training and vitamin D supplementation in institutionalized elderly women. A 6 month randomized controlled trial. Gait Posture. 2011;33(3):466–72. CrossRefPubMed
Kirchner E. Pflegerische Interventionen und Möglichkeiten bei krebstherapiebedingter Polyneuropathie. DLH-INFO. 2008;37:19–21.
Schonsteiner SS, Bauder Missbach H, Benner A, Mack S, Hamel T, Orth M, Landwehrmeyer B, Sussmuth SD, Geitner C, Mayer-Steinacker R, et al. A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercises. Exp Hematol Oncol. 2017;6:5. CrossRefPubMedPubMedCentral
Anna H. The effects of sensorimotor-training and whole body vibration on patients with chemotherapy induced peripheral neuropathy in the aftercare- a pilot study. Cologne: University of Cologne; 2014.
White CM, Pritchard J, Turner-Stokes L. Exercise for people with peripheral neuropathy. Cochrane Database Syst Rev. 2004;(4):CD003904. https://doi.org/10.1002/14651858.CD003904.pub2.
Coren S. The lateral preference inventory for measurement of handedness, footedness, eyedness, and earedness: norms for young adults. Bull Psychon Soc. 1993;31:1–3. CrossRef
Taube W, Gruber M, Gollhofer A. Spinal and supraspinal adaptations associated with balance training and their functional relevance. Acta Physiol (Oxf). 2008;193(2):101–16. CrossRef
Hayes S, Newman B. Exercise in cancer recovery: An overview of the evidence. Cancer Forum. 2006;30:13–7.
Aaronson NKAS, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SBHJ, Kaasa S, Klee MC, Osoba D, Razavi D, Rofe PB, Schraub S, SM SKCA, Takeda F. The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76. CrossRefPubMed
Emery CF. Cognitive functioning among patients in cardiopulmonary rehabilitation. J Cardpulm Rehabil. 1997;17(6):407–10. CrossRef
Frey IBA, Grathwohl D, Keul J. Freiburger questionnaire of physical activity- devlopment, evaluation and application. SozPraventivmed. 1999;44(2):55–64.
Royston P, Barthel FM-S. Projection of power and events in clinical trials with a time-to-event outcome. Stata J. 2010;10(3):386.
- The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP
Helmar C. Lehmann
Freerk T. Baumann
- BioMed Central
Neu im Fachgebiet Onkologie
Mail Icon II